Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · IEX Real-Time Price · USD
+0.080 (4.62%)
Jun 14, 2024, 10:02 AM EDT - Market open

Virax Biolabs Group Statistics

Total Valuation

VRAX has a market cap or net worth of $3.90 million. The enterprise value is -$840,084.

Market Cap 3.90M
Enterprise Value -840,084

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, before market open.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

VRAX has 2.36 million shares outstanding. The number of shares has increased by 664.03% in one year.

Shares Outstanding 2.36M
Shares Change (YoY) +664.03%
Shares Change (QoQ) +67.01%
Owned by Insiders (%) 26.80%
Owned by Institutions (%) 0.76%
Float 1.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 51.53
Forward PS n/a
PB Ratio 0.65
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.59, with a Debt / Equity ratio of 0.03.

Current Ratio 7.59
Quick Ratio n/a
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -432.43

Financial Efficiency

Return on equity (ROE) is -129.10% and return on invested capital (ROIC) is -107.42%.

Return on Equity (ROE) -129.10%
Return on Assets (ROA) -112.40%
Return on Capital (ROIC) -107.42%
Revenue Per Employee $7,209
Profits Per Employee -$629,412
Employee Count 11
Asset Turnover 0.01
Inventory Turnover 3.08


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -56.87% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -56.87%
50-Day Moving Average 0.91
200-Day Moving Average 1.66
Relative Strength Index (RSI) 69.53
Average Volume (30 Days) 1,414,179

Short Selling Information

The latest short interest is 47,044, so 1.99% of the outstanding shares have been sold short.

Short Interest 47,044
Short Previous Month 600
Short % of Shares Out 1.99%
Short % of Float 3.55%
Short Ratio (days to cover) 0.02

Income Statement

In the last 12 months, VRAX had revenue of $79,301 and -$6.92 million in losses. Loss per share was -$2.94.

Revenue 79,301
Gross Profit 9,035
Operating Income -7.00M
Pretax Income -6.92M
Net Income -6.92M
EBIT -6.91M
Loss Per Share -$2.94
Full Income Statement

Balance Sheet

The company has $5.11 million in cash and $181,706 in debt, giving a net cash position of $4.93 million or $2.09 per share.

Cash & Cash Equivalents 5.11M
Total Debt 181,706
Net Cash 4.93M
Net Cash Per Share $2.09
Equity / Book Value 6.33M
Book Value Per Share 2.68
Working Capital 5.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.34 million and capital expenditures -$708,181, giving a free cash flow of -$6.05 million.

Operating Cash Flow -5.34M
Capital Expenditures -708,181
Free Cash Flow -6.05M
FCF Per Share -$3.41
Full Cash Flow Statement


Gross margin is 11.39%, with operating and profit margins of -8,825.12% and -8,730.70%.

Gross Margin 11.39%
Operating Margin -8,825.12%
Pretax Margin -8,730.70%
Profit Margin -8,730.70%
EBITDA Margin n/a
EBIT Margin -8,710.56%
FCF Margin -7,628.04%

Dividends & Yields

VRAX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -664.03%
Shareholder Yield -664.03%
Earnings Yield -169.44%
FCF Yield -148.04%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on December 18, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Dec 18, 2023
Split Type Reverse
Split Ratio 1:10


VRAX has an Altman Z-Score of -2.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.63
Piotroski F-Score 3